glp-1 kidney disease receptor agonists and next-generation metabolic hormone therapies in chronic GLP-1 Receptor Agonists in the

Altered DNA methylation patterns have been identified in clinical RA

On Thursday, Pfizer reported long-awaited results from a 20-person study of an anti-obesity pill that previously ran into trouble because of side effects

NR, not reported, PR, partial response

Progress in diagnostics have been made, with the integration of molecular characterization, genomics, and non-invasive liquid biopsies, in addition to traditional imaging and histopathology

In 2019, a proof of concept, phase IIa open label study in Germany aimed to evaluate the safety and efficacy of melanotan I implants in patients with XP [12]

Safwan M, Bourgleh MS, Alotaibi SA, Alotaibi E, Al-Ruqi A, El Raeya F